Global Closed-loop Automated Insulin Delivery (AID) System Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
According to our (Global Info Research) latest study, the global Closed-loop Automated Insulin Delivery (AID) System market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Closed-loop Automated Insulin Delivery (AID) System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Closed-loop Automated Insulin Delivery (AID) System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Closed-loop Automated Insulin Delivery (AID) System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Closed-loop Automated Insulin Delivery (AID) System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Closed-loop Automated Insulin Delivery (AID) System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Closed-loop Automated Insulin Delivery (AID) System, with price, sales quantity, revenue, and global market share of Closed-loop Automated Insulin Delivery (AID) System from 2019 to 2024.
Chapter 3, the Closed-loop Automated Insulin Delivery (AID) System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Closed-loop Automated Insulin Delivery (AID) System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Closed-loop Automated Insulin Delivery (AID) System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Closed-loop Automated Insulin Delivery (AID) System.
Chapter 14 and 15, to describe Closed-loop Automated Insulin Delivery (AID) System sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Closed-loop Automated Insulin Delivery (AID) System market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Closed-loop Automated Insulin Delivery (AID) System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Closed-loop Automated Insulin Delivery (AID) System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Closed-loop Automated Insulin Delivery (AID) System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Closed-loop Automated Insulin Delivery (AID) System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Hybrid Closed Loop Systems
- DIY Closed Loop Systems
- Children with Type 1 Diabetes
- Adults with Type 1 Diabetes
- Medtronic
- Tandem Diabetes Care
- Admetsys
- Insulet
- Defymed
- Beta Bionics (iLet)
- Bigfoot Biomedical
- Dexcom
- MicroTech Medical (Hangzhou) Co., Ltd.
- Medtrum
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Closed-loop Automated Insulin Delivery (AID) System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Closed-loop Automated Insulin Delivery (AID) System, with price, sales quantity, revenue, and global market share of Closed-loop Automated Insulin Delivery (AID) System from 2019 to 2024.
Chapter 3, the Closed-loop Automated Insulin Delivery (AID) System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Closed-loop Automated Insulin Delivery (AID) System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Closed-loop Automated Insulin Delivery (AID) System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Closed-loop Automated Insulin Delivery (AID) System.
Chapter 14 and 15, to describe Closed-loop Automated Insulin Delivery (AID) System sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Hybrid Closed Loop Systems
1.3.3 DIY Closed Loop Systems
1.4 Market Analysis by Application
1.4.1 Overview: Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children with Type 1 Diabetes
1.4.3 Adults with Type 1 Diabetes
1.5 Global Closed-loop Automated Insulin Delivery (AID) System Market Size & Forecast
1.5.1 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (2019-2030)
1.5.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.1.4 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic Recent Developments/Updates
2.2 Tandem Diabetes Care
2.2.1 Tandem Diabetes Care Details
2.2.2 Tandem Diabetes Care Major Business
2.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.2.4 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Tandem Diabetes Care Recent Developments/Updates
2.3 Admetsys
2.3.1 Admetsys Details
2.3.2 Admetsys Major Business
2.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.3.4 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Admetsys Recent Developments/Updates
2.4 Insulet
2.4.1 Insulet Details
2.4.2 Insulet Major Business
2.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.4.4 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Insulet Recent Developments/Updates
2.5 Defymed
2.5.1 Defymed Details
2.5.2 Defymed Major Business
2.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.5.4 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Defymed Recent Developments/Updates
2.6 Beta Bionics (iLet)
2.6.1 Beta Bionics (iLet) Details
2.6.2 Beta Bionics (iLet) Major Business
2.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.6.4 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Beta Bionics (iLet) Recent Developments/Updates
2.7 Bigfoot Biomedical
2.7.1 Bigfoot Biomedical Details
2.7.2 Bigfoot Biomedical Major Business
2.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.7.4 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bigfoot Biomedical Recent Developments/Updates
2.8 Dexcom
2.8.1 Dexcom Details
2.8.2 Dexcom Major Business
2.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.8.4 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Dexcom Recent Developments/Updates
2.9 MicroTech Medical (Hangzhou) Co., Ltd.
2.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Details
2.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Major Business
2.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
2.10 Medtrum
2.10.1 Medtrum Details
2.10.2 Medtrum Major Business
2.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.10.4 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Medtrum Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CLOSED-LOOP AUTOMATED INSULIN DELIVERY (AID) SYSTEM BY MANUFACTURER
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Manufacturer (2019-2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Manufacturer (2019-2024)
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Closed-loop Automated Insulin Delivery (AID) System by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Closed-loop Automated Insulin Delivery (AID) System Manufacturer Market Share in 2023
3.4.3 Top 6 Closed-loop Automated Insulin Delivery (AID) System Manufacturer Market Share in 2023
3.5 Closed-loop Automated Insulin Delivery (AID) System Market: Overall Company Footprint Analysis
3.5.1 Closed-loop Automated Insulin Delivery (AID) System Market: Region Footprint
3.5.2 Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Type Footprint
3.5.3 Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2030)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2030)
4.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2019-2030)
4.2 North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.3 Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.4 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.5 South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.6 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
5.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2019-2030)
5.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
6.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2019-2030)
6.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
7.2 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
7.3 North America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
7.3.1 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
7.3.2 North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
8.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
8.3 Europe Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
8.3.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
8.3.2 Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
9.3.1 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
10.2 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
10.3 South America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
10.3.1 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
10.3.2 South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
11.3.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Closed-loop Automated Insulin Delivery (AID) System Market Drivers
12.2 Closed-loop Automated Insulin Delivery (AID) System Market Restraints
12.3 Closed-loop Automated Insulin Delivery (AID) System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Closed-loop Automated Insulin Delivery (AID) System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Closed-loop Automated Insulin Delivery (AID) System
13.3 Closed-loop Automated Insulin Delivery (AID) System Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Closed-loop Automated Insulin Delivery (AID) System Typical Distributors
14.3 Closed-loop Automated Insulin Delivery (AID) System Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Hybrid Closed Loop Systems
1.3.3 DIY Closed Loop Systems
1.4 Market Analysis by Application
1.4.1 Overview: Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children with Type 1 Diabetes
1.4.3 Adults with Type 1 Diabetes
1.5 Global Closed-loop Automated Insulin Delivery (AID) System Market Size & Forecast
1.5.1 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (2019-2030)
1.5.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.1.4 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic Recent Developments/Updates
2.2 Tandem Diabetes Care
2.2.1 Tandem Diabetes Care Details
2.2.2 Tandem Diabetes Care Major Business
2.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.2.4 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Tandem Diabetes Care Recent Developments/Updates
2.3 Admetsys
2.3.1 Admetsys Details
2.3.2 Admetsys Major Business
2.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.3.4 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Admetsys Recent Developments/Updates
2.4 Insulet
2.4.1 Insulet Details
2.4.2 Insulet Major Business
2.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.4.4 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Insulet Recent Developments/Updates
2.5 Defymed
2.5.1 Defymed Details
2.5.2 Defymed Major Business
2.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.5.4 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Defymed Recent Developments/Updates
2.6 Beta Bionics (iLet)
2.6.1 Beta Bionics (iLet) Details
2.6.2 Beta Bionics (iLet) Major Business
2.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.6.4 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Beta Bionics (iLet) Recent Developments/Updates
2.7 Bigfoot Biomedical
2.7.1 Bigfoot Biomedical Details
2.7.2 Bigfoot Biomedical Major Business
2.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.7.4 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bigfoot Biomedical Recent Developments/Updates
2.8 Dexcom
2.8.1 Dexcom Details
2.8.2 Dexcom Major Business
2.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.8.4 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Dexcom Recent Developments/Updates
2.9 MicroTech Medical (Hangzhou) Co., Ltd.
2.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Details
2.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Major Business
2.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
2.10 Medtrum
2.10.1 Medtrum Details
2.10.2 Medtrum Major Business
2.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.10.4 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Medtrum Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CLOSED-LOOP AUTOMATED INSULIN DELIVERY (AID) SYSTEM BY MANUFACTURER
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Manufacturer (2019-2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Manufacturer (2019-2024)
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Closed-loop Automated Insulin Delivery (AID) System by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Closed-loop Automated Insulin Delivery (AID) System Manufacturer Market Share in 2023
3.4.3 Top 6 Closed-loop Automated Insulin Delivery (AID) System Manufacturer Market Share in 2023
3.5 Closed-loop Automated Insulin Delivery (AID) System Market: Overall Company Footprint Analysis
3.5.1 Closed-loop Automated Insulin Delivery (AID) System Market: Region Footprint
3.5.2 Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Type Footprint
3.5.3 Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2030)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2030)
4.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2019-2030)
4.2 North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.3 Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.4 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.5 South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.6 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
5.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2019-2030)
5.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
6.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2019-2030)
6.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
7.2 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
7.3 North America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
7.3.1 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
7.3.2 North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
8.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
8.3 Europe Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
8.3.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
8.3.2 Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
9.3.1 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
10.2 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
10.3 South America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
10.3.1 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
10.3.2 South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
11.3.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Closed-loop Automated Insulin Delivery (AID) System Market Drivers
12.2 Closed-loop Automated Insulin Delivery (AID) System Market Restraints
12.3 Closed-loop Automated Insulin Delivery (AID) System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Closed-loop Automated Insulin Delivery (AID) System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Closed-loop Automated Insulin Delivery (AID) System
13.3 Closed-loop Automated Insulin Delivery (AID) System Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Closed-loop Automated Insulin Delivery (AID) System Typical Distributors
14.3 Closed-loop Automated Insulin Delivery (AID) System Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 6. Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Medtronic Recent Developments/Updates
Table 8. Tandem Diabetes Care Basic Information, Manufacturing Base and Competitors
Table 9. Tandem Diabetes Care Major Business
Table 10. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 11. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Tandem Diabetes Care Recent Developments/Updates
Table 13. Admetsys Basic Information, Manufacturing Base and Competitors
Table 14. Admetsys Major Business
Table 15. Admetsys Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 16. Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Admetsys Recent Developments/Updates
Table 18. Insulet Basic Information, Manufacturing Base and Competitors
Table 19. Insulet Major Business
Table 20. Insulet Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 21. Insulet Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Insulet Recent Developments/Updates
Table 23. Defymed Basic Information, Manufacturing Base and Competitors
Table 24. Defymed Major Business
Table 25. Defymed Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 26. Defymed Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Defymed Recent Developments/Updates
Table 28. Beta Bionics (iLet) Basic Information, Manufacturing Base and Competitors
Table 29. Beta Bionics (iLet) Major Business
Table 30. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 31. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Beta Bionics (iLet) Recent Developments/Updates
Table 33. Bigfoot Biomedical Basic Information, Manufacturing Base and Competitors
Table 34. Bigfoot Biomedical Major Business
Table 35. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 36. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Bigfoot Biomedical Recent Developments/Updates
Table 38. Dexcom Basic Information, Manufacturing Base and Competitors
Table 39. Dexcom Major Business
Table 40. Dexcom Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 41. Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Dexcom Recent Developments/Updates
Table 43. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. MicroTech Medical (Hangzhou) Co., Ltd. Major Business
Table 45. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 46. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
Table 48. Medtrum Basic Information, Manufacturing Base and Competitors
Table 49. Medtrum Major Business
Table 50. Medtrum Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 51. Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Medtrum Recent Developments/Updates
Table 53. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Closed-loop Automated Insulin Delivery (AID) System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 57. Head Office and Closed-loop Automated Insulin Delivery (AID) System Production Site of Key Manufacturer
Table 58. Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Type Footprint
Table 59. Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Application Footprint
Table 60. Closed-loop Automated Insulin Delivery (AID) System New Market Entrants and Barriers to Market Entry
Table 61. Closed-loop Automated Insulin Delivery (AID) System Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 63. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2024) & (K Units)
Table 64. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2025-2030) & (K Units)
Table 65. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2025-2030) & (USD Million)
Table 67. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2019-2024) & (US$/Unit)
Table 68. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2025-2030) & (US$/Unit)
Table 69. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 70. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 71. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2024) & (US$/Unit)
Table 74. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2025-2030) & (US$/Unit)
Table 75. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2024) & (US$/Unit)
Table 80. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2025-2030) & (US$/Unit)
Table 81. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 82. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 83. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 84. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 85. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 86. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 87. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 88. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 90. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 91. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 92. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 93. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 94. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 95. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 96. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2025-2030) & (USD Million)
Table 105. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 106. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 107. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 108. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 109. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 110. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 111. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Closed-loop Automated Insulin Delivery (AID) System Raw Material
Table 122. Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System Raw Materials
Table 123. Closed-loop Automated Insulin Delivery (AID) System Typical Distributors
Table 124. Closed-loop Automated Insulin Delivery (AID) System Typical Customers
Table 1. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 6. Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Medtronic Recent Developments/Updates
Table 8. Tandem Diabetes Care Basic Information, Manufacturing Base and Competitors
Table 9. Tandem Diabetes Care Major Business
Table 10. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 11. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Tandem Diabetes Care Recent Developments/Updates
Table 13. Admetsys Basic Information, Manufacturing Base and Competitors
Table 14. Admetsys Major Business
Table 15. Admetsys Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 16. Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Admetsys Recent Developments/Updates
Table 18. Insulet Basic Information, Manufacturing Base and Competitors
Table 19. Insulet Major Business
Table 20. Insulet Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 21. Insulet Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Insulet Recent Developments/Updates
Table 23. Defymed Basic Information, Manufacturing Base and Competitors
Table 24. Defymed Major Business
Table 25. Defymed Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 26. Defymed Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Defymed Recent Developments/Updates
Table 28. Beta Bionics (iLet) Basic Information, Manufacturing Base and Competitors
Table 29. Beta Bionics (iLet) Major Business
Table 30. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 31. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Beta Bionics (iLet) Recent Developments/Updates
Table 33. Bigfoot Biomedical Basic Information, Manufacturing Base and Competitors
Table 34. Bigfoot Biomedical Major Business
Table 35. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 36. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Bigfoot Biomedical Recent Developments/Updates
Table 38. Dexcom Basic Information, Manufacturing Base and Competitors
Table 39. Dexcom Major Business
Table 40. Dexcom Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 41. Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Dexcom Recent Developments/Updates
Table 43. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. MicroTech Medical (Hangzhou) Co., Ltd. Major Business
Table 45. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 46. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
Table 48. Medtrum Basic Information, Manufacturing Base and Competitors
Table 49. Medtrum Major Business
Table 50. Medtrum Closed-loop Automated Insulin Delivery (AID) System Product and Services
Table 51. Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Medtrum Recent Developments/Updates
Table 53. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Closed-loop Automated Insulin Delivery (AID) System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 57. Head Office and Closed-loop Automated Insulin Delivery (AID) System Production Site of Key Manufacturer
Table 58. Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Type Footprint
Table 59. Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Application Footprint
Table 60. Closed-loop Automated Insulin Delivery (AID) System New Market Entrants and Barriers to Market Entry
Table 61. Closed-loop Automated Insulin Delivery (AID) System Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 63. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2024) & (K Units)
Table 64. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2025-2030) & (K Units)
Table 65. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2025-2030) & (USD Million)
Table 67. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2019-2024) & (US$/Unit)
Table 68. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2025-2030) & (US$/Unit)
Table 69. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 70. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 71. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2024) & (US$/Unit)
Table 74. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2025-2030) & (US$/Unit)
Table 75. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2024) & (US$/Unit)
Table 80. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2025-2030) & (US$/Unit)
Table 81. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 82. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 83. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 84. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 85. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 86. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 87. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 88. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 90. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 91. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 92. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 93. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 94. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 95. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 96. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2025-2030) & (USD Million)
Table 105. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 106. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 107. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 108. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 109. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 110. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 111. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Closed-loop Automated Insulin Delivery (AID) System Raw Material
Table 122. Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System Raw Materials
Table 123. Closed-loop Automated Insulin Delivery (AID) System Typical Distributors
Table 124. Closed-loop Automated Insulin Delivery (AID) System Typical Customers
LIST OF FIGURES
Figure 1. Closed-loop Automated Insulin Delivery (AID) System Picture
Figure 2. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type in 2023
Figure 4. Hybrid Closed Loop Systems Examples
Figure 5. DIY Closed Loop Systems Examples
Figure 6. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application in 2023
Figure 8. Children with Type 1 Diabetes Examples
Figure 9. Adults with Type 1 Diabetes Examples
Figure 10. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Closed-loop Automated Insulin Delivery (AID) System Price (2019-2030) & (US$/Unit)
Figure 14. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Closed-loop Automated Insulin Delivery (AID) System by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 Closed-loop Automated Insulin Delivery (AID) System Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 Closed-loop Automated Insulin Delivery (AID) System Manufacturer (Revenue) Market Share in 2023
Figure 19. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2019-2030)
Figure 31. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 44. France Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Region (2019-2030)
Figure 52. China Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 55. India Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 72. Closed-loop Automated Insulin Delivery (AID) System Market Drivers
Figure 73. Closed-loop Automated Insulin Delivery (AID) System Market Restraints
Figure 74. Closed-loop Automated Insulin Delivery (AID) System Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System in 2023
Figure 77. Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
Figure 78. Closed-loop Automated Insulin Delivery (AID) System Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Closed-loop Automated Insulin Delivery (AID) System Picture
Figure 2. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type in 2023
Figure 4. Hybrid Closed Loop Systems Examples
Figure 5. DIY Closed Loop Systems Examples
Figure 6. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application in 2023
Figure 8. Children with Type 1 Diabetes Examples
Figure 9. Adults with Type 1 Diabetes Examples
Figure 10. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Closed-loop Automated Insulin Delivery (AID) System Price (2019-2030) & (US$/Unit)
Figure 14. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Closed-loop Automated Insulin Delivery (AID) System by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 Closed-loop Automated Insulin Delivery (AID) System Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 Closed-loop Automated Insulin Delivery (AID) System Manufacturer (Revenue) Market Share in 2023
Figure 19. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2019-2030)
Figure 31. Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 44. France Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Region (2019-2030)
Figure 52. China Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 55. India Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030) & (USD Million)
Figure 72. Closed-loop Automated Insulin Delivery (AID) System Market Drivers
Figure 73. Closed-loop Automated Insulin Delivery (AID) System Market Restraints
Figure 74. Closed-loop Automated Insulin Delivery (AID) System Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System in 2023
Figure 77. Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
Figure 78. Closed-loop Automated Insulin Delivery (AID) System Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
